At GSK, our Ellipta portfolio delivers an effective and simple approach to COPD treatment, whilst our Ellipta device is the only once-daily inhaler that enables device continuity for patients with COPD.
As well as our Ellipta portfolio of COPD treatments, we are also committed to improving patient outcomes through the resources we offer. Our Ellipta demonstration device can help you demonstrate correct use of the Ellipta inhaler to your patients.
IMPORTANT: The Ellipta demonstration device is intended for demonstration only and not for patient use. Patients should not inhale from the demonstration device.
Developed in association with INNOVIVA.